Conference Summary Race to the Test – December 10, 2020
Expert discussions on the critical issues and presentations of the most promising solutions. Insight on COVID-19 — testing from those in the midst of the action.
CEOs from companies with technologies that are shaping the landscape give their take on the future of COVID testing. Panel Discussion.
Panelists (clockwise) Quanterix CEO Kevin Hrusovsky is a biotech industry icon and founder of Powering Precision Health, Brett Johnson is founder of The Virus Project Altru Institute. Arvind Kothandaraman leads the specialty diagnostics business at PerkinElmer. Mirimus Labs CEO Prem Premsrirut pooled testing technology SalivaClear keeps schools open and safe. Watch Panel HERE
Presenting firms shared Commercial status of promising new technologies. Company Presentations.
Mirimus Labs CEO Prem Premsrirut licensed a COVID-19 pooled testing technology developed at Yale and created SalivaClear , a way to use this technology to keep schools open and safe. She is a mother who saw the critical need and used her talents as a scientist and entrepreneur to help keep schools open in the New York and New England region. Prem is a pioneer in RNAi therapeutic design and CRISPR/Cas9 gene editing technology implementation for preclinical studies. She received a B.A. in Molecular Cell Biology and Biochemistry from UC Berkeley. She is also founder of the Mobilizing Foundation which is committed to the eradication of COVID-19 and the prevention of future pandemics through collaborative scientific research and massive surveillance testing. VIEW COMPANY VIDEO PRESENTATION (9:34)
ABOUT: This is the first conference of The Virus Project which was created to provide a connecting platform for the brightest ideas and most capable individuals interested in collaboration to find solutions. It is an initiative of the Altru Institute, a New York-based think tank focused on addressing complex challenges through collaboration.